The Drugs That Are Gaining On Ozempic

[ad_1] If they prove to work safely, the therapies could help people lose so much weight that they supplant bariatric surgery. [ad_2] Source link

Ozempic Might Help You Drink and Smoke Less

[ad_1] Diabetes drugs like Ozempic are emerging as a surprising and potentially game-changing way to treat addictions, including alcohol-use disorder and smoking, because of the effects they have on the…

Wegovy Maker to Limit Starter-Dose Supplies in U.S. as Demand Surges

[ad_1] Lower-strength starter doses of the obesity drug will be held back in the U.S. to safeguard supplies, said pharmaceutical company Novo Nordisk. [ad_2] Source link

Elevance Health Earnings Rise With Uptick in Premiums, Enrollment

[ad_1] The health insurer’s operating revenue in the first quarter was lifted by membership growth in Medicaid and Medicare Advantage. [ad_2] Source link

Demand for Obesity Drugs Has Insurers Paying Close Attention

[ad_1] Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results [ad_2] Source link

Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.

[ad_1] Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. [ad_2] Source link

Novo Nordisk Is Raising the Bar on Diabetes, Obesity Drugs — Analysis

[ad_1] Novo Nordisk is currently relaunching its diabetes drug Wegovy in the U.S., with rising capacity putting the company in a solid position to boost growth, according to analysts. [ad_2]…

Americans to Be Barred From Buying Ozempic in British Columbia

[ad_1] Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose weight. [ad_2] Source link

Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%

[ad_1] Health Sanofi says it would cap patients’ out-of-pocket costs for Lantus insulin at $35 a month [ad_2] Source link

WSJ News Exclusive | Novo Nordisk to Slash Insulin Prices by Up to 75%

[ad_1] WSJ News Exclusive Health The insulin maker is the latest to plan sharp price cuts for the diabetes treatments to make them more affordable [ad_2] Source link